Home About Us Contact Us

 

Table of Content - Volume 16 Issue 3 - December 2020

  

    

A study of prognostic significance of serum magnesium concentration in type ii diabetes mellitus in a tertiary care hospital in Puducherry

 

VKM Pavithraa1, P Muraliswaran2*, M Priyatharshini3, Hussain4, Susi Ganesan5

 

1II MBBS, 2Professor & HOD, 3Associate Professor, Department of Biochemistry, 5Statistician. Sri Venkateshwaraa Medical College Hospital and Research Centre, INDIA.

Email: drpmwaran@gmail.com

 

Abstract              Background: According to the Indian Heart Association, India is projected to be home to 109 million individuals with diabetes by 2035. Type 2 diabetes mellitus (DM2) is often accompanied by alteration of Mg status. Magnesium(Mg) is one of the major intracellular cation and it has been suggested that hypomagnesaemia may induce altered cellular glucose transport, reduced pancreatic insulin secretion, defective postreceptor insulin signaling, and/or altered insulin–insulin receptor interactions. with all these, the study will be undertaken to correlate the levels of serum magnesium and blood glucose in type II diabetic population in our hospital. Materials and Methods; In our cross sectional study, totally 90 cases were involved and divided into three groups., Group 1-control,Group 2 – Type 2 DM less than 5 years duration – 30 and Group 3 – Type 2 DM more than 5 years duration – 30.Methods; Estimation; Fasting(10 hours) and postprandial (2 hour) blood sugar were estimated by enzymatic method with serum mg by an enzymatic end point method. Urine examination done for sugar and proteinuria. Statistical Analysis: by using SPSS package for windows version 17.0. Scientific research committee and ethical committee clearance were obtained. Observations; In our study, there was a positive Correlation between the HbA1C, fasting and post prandial blood glucose but no significant correlation with magnesium. The fasting and post prandial blood glucose values are inversely correlated with magnesium. There was a negative correlation between serum mg and HbA1C in all the 3 groups by pearson correlation analysis. Finally, there were no significance r and p-values between the sr.mg and HbA1C. Conclusion: To conclude, serum magnesium levels were lower in DM2 patients when compared with non-diabetic controls. Because of this low level of Mg2+, which reduces insulin sensitivity and may increase risk of secondary complications like retinopathy, hypertension and dyslipidaemia, and by giving oral Mg supplements appear to be useful in patients with DM2 to restore Mg deficiencies.

Key words; Diabetes mellitus, hypomagnesemia, insulin sensitivity, blood sugar and serum magnesium.

 

INTRODUCTION

Globally, an estimated 422 million adults are living with diabetes mellitus(DM), according to the latest 2016 data from the World Health Organization (WHO)1 According to the Indian Heart Association, India is projected to be home to 109 million individuals with diabetes by 2035.1 The high incidence is attributed to a combination of genetic susceptibility plus adoption of a high-calorie, low-activity lifestyle by India's growing middle class.3 Magnesium(Mg) is one of the major intracellular cation and is an important cofactor for various enzymes, transporters, and nucleic acids that are essential for normal cellular function, replication, and energy metabolism.4 It has been suggested that hypomagnesaemia may induce altered cellular glucose transport, reduced pancreatic insulin secretion, defective postreceptor insulin signalling, and/or altered insulin–insulin receptor interactions.5 Type 2 diabetes mellitus (DM2) is often accompanied by alteration of Mg status. An increased prevalence of Mg deficits have been identified in DM2 patients, especially in those with poorly controlled glycemic profiles, with longer duration of the disease and with the presence of micro- and macrovascular chronic complications.6 The possible link between Mg deficiency and reduced insulin sensitivity is the presence of oxidative stress and/or inflammation. Thus, free radicals are often increased in DM2, hypertension, metabolic syndrome and aging, conditions also associated with Mg deficits.7 In one retrospective study, an association between low serum Mg levels and a significantly faster rate of renal function deterioration in patients with type 2 diabetes was reported.8 Mg has been directly implicated in hypocalcemia, tetany, hypokalemia, arrhythmias, stroke, ischemic heart disease, electrolyte abnormality and bronchial asthma.9 So, with all the above aspects, the study will be undertaken to correlate the levels of serum magnesium and blood glucose in type II diabetic population (Men / Women) in our tertiary care hospital.

Objectives

  1. To estimate the levels of serum magnesium and blood glucose concentration in Type 2 diabetes mellitus patients.
  2. To find out the correlation between serum magnesium and blood glucose levels in Type 2 diabetes mellitus patients.

MATERIALS AND METHODS

Study design: Cross sectional study,

Study area: SVMCH and RC, Ariyur, Puducherry. Study population – 90 cases,

Group 1 - control subjects – 30

Group 2 – Type 2 DM less than 5 years – 30

Group 3 – Type 2 DM more than 5 years – 30.(All new and old cases of Type 2 diabetes mellitus patients, aged between 35 to 60 years attended medicine OP department and diabetology clinic, SVMCH and RC, Ariyur) Study duration: 2 months (July and August 2018).

Inclusion Criteria: All new and old cases of Type 2 diabetes mellitus patients, aged between 35 to 60 years attended medicine OP department and diabetology clinic, at Sri Venkateshwaraa Medical College and Hospital, Ariyur, Puducherry.

Exclusion Criteria: Patients with nephropathy. Patients who suffered coronary artery diseases in last six months. Patients on drug therapy-diuretics. Patients with history of alcoholism. Patients on magnesium supplementation. GIT problems-Malabsorption and Chronic diarrhoea.

Methods

Overnight fasting, venous blood sample (after at least 10 hours) was collected for the measurements of serum magnesium and blood glucose. Estimation of blood glucose;Fasting and postprandial (2 hour) blood sugar (FBS and PPBS) were estimated by Glucose Oxidase-Peroxidase (GOD-POD) enzymatic end point method. Glycated haemoglobin(HbA1C) were estimated by immunoturbidity method. Estimation of Serum Magnesium;-It is an enzymatic end point method. normal fasting is 70-110mg/dl and post prandial is 110-140mg/dl. The normal serum magnesium level is ranging from 1.8 mg /dl to 3.6 mg /dl. Serum magnesium levels < 1.5 mg/dl is considered as low mg level in this study. Urine examination done for benedict test and proteinuria.

Statistical Analysis: The data were collected, recorded and analyzed statistically to determine the significance of different parameters by using SPSS package for windows version 17.0. Scientific research committee and ethical committee clearance were obtained from the concerned committees from our institution.


RESULTS

Table 1: clinical and biochemical characteristics of the subjects

 

Group-1 (n=30)

Group-2 (n=30)

Group-3

(n=30)

p value

Age (Year)

52.67±14.6

56.93±10.7

53.63±9.6

0.3473

Gender (F/M)

12/18

16/14

13/17

0.5586

Blood sugar level fasting (70-110 mg /dl)

 

96.80±10.8

 

187.83±69.4

 

197.57±92.4

 

0.0001*

Blood sugar level -

Postprandial (110-140 mg /dl)

 

122.70±9.5

 

292.77±77.8

 

298.53±66.9

 

0.0001*

HbA1c <6%

4.81±0.5

6.72±3.3

6.72±3.3

0.0090*

Sr. Mg (mg/dl) 1.6-2.6

1.99±0.4

1.94±0.7

2.04±0.9

0.8574

p<0.05 is consider as significant.

 

 

Table 2: Correlation between Sr. Mg. with Fasting and PP blood sugar

 

Group-1 (n=30)

Fasting-

Blood sugar(mg/dl)

PP- Blood sugar(mg/dl)

Group 1

r value

-0.033

0.121

P value

0.864

0.525

Group 2

r value

0.035

0.274

p value

0.855

0.142

Group 3

r value

0.001

0.336

p value

0.998

0.070

 

Figure 1                                                                           Figure 2                                                                      Figure 3

Figure 1: Correlation between Sr. Mg. with HbA1C in group-1; Figure 2: Correlation between Sr. Mg. with HbA1C in group-2; Figure 3: Correlation between Sr. Mg. with HbA1C in group-3

 

Table 6: Correlation between HbA1c with Sr. Mg (mg/dl)

Cases

r value

p value

Group 1

-0.314

0.091

Group 2

-0.879

0.001

Group 3

-0.835

0.001

 


OBSERVATIONS

In our study, mean and std deviation of all the 3 groups were 52±14.6,56±10.7 and 53.63±9.6 respectively.(Table-1).In gender area, the p-value was 0.55 which was not significant in our study. There was a positive Correlation between the parameters of glycemic status ie-HbA1C, fasting and post prandial blood glucose but no significant correlation with magnesium.( Table -1).In Table -2,the fasting and post prandial blood glucose values are inversely correlated with magnesium. In Table -3,4,5,there was a negative correlation between serum mg and HbA1C in all the 3 groups by pearson correlation analysis. In Table-6 also there was no significance r and p-values between the sr.mg and HbA1C.

 

DISCUSSION

Hypomagnesemia is a good prognostic factor in DM2 and associated with various complications. Hence, it is very useful to measure the serum magnesium levels in patients with type DM and probably correlates their relationship with various systemic complications. So, we have selected the patients who attended the medicine and diabetology OPD, participated in our study. Patients with HbA1c < 7.0% were assigned to Group 2 while patients who had HbA1c > 7.0% were assigned to Group 3.Group 1 act as a control.In this study, we observed more number of cases with low levels of magnesium in group 3 where HbA1c was above 7% when compared to group 2 where HbA1c was less than 7%. But, there was a negative correlation between the parameters of glycemic status and serum magnesium. In another Libyan study,DM2 patients serum magnesium levels were significantly lower than normal control subjects. Serum magnesium of diabetic patients showed significant negative correlations with duration of disease, and glycemic control as measured by HbA1c, and near significant negative correlation with FBS. No significant correlations were found between magnesium level and BMI or age.10.One more study done by De Valk HW found that patients with severe retinopathy have a lower plasma magnesium level compared to patients without retinopathy and a prospective study has shown the plasma magnesium level to be inversely related to occurrence or progression of retinopathy.11.In a recent Study conducted by Senthil et al. stated that a significant inverse relationship between Serum Mg and HbA1C values in south india[12].Causes for the low Mg levels in DM2 are,a low Mg intake and an increased Mg urinary loss13 and the use of loop and thiazide diuretics, often prescribed in diabetic patients with hypertension and/or cardiovascular diseases, also promote Mg loss14. Resnick and associates suggest that extracellular and intracellular magnesium deficiency is typical in chronic, stable, mild DM2 and may be a strong predisposing factor for the development of the excess cardiovascular morbidity associated with diabetes15.Garland HO in his study speculated on a potential link between the magnesium deficit in diabetes and several diabetic complications including cardiovascular problems and retionopathy[16] and Sharma et al.. also observed that those who had low serum magnesium levels were prone for diabetes related complications (hypertension, dyslipidaemia, and retinopathy) [17].In a study, done by Supriya et al.. and Ankush RD et al.. ,they have found out the positive correlation ie, there was significant decrease in serum magnesium level in type 2 DM as compared to controls18,19.

 

CONCLUSION

To conclude, in our study, serum magnesium levels were lower in DM2 patients when compared with non-diabetic controls. Because of this low level of Mg2+, which reduces insulin sensitivity and may increase risk of secondary complications like retinopathy, hypertension and dyslipidaemia, it may be prudent in clinical practice to periodically investigate plasma Mg2+ concentrations in diabetic patients. If plasma Mg2+ is low, an intervention to increase dietary intake of magnesium may be beneficial. oral Mg supplements appear to be useful in persons with DM2 to restore Mg deficiencies, to improve insulin resistance, oxidative stress, and systemic inflammation[20] and have been shown to improve fasting and postprandial glucose levels and insulin sensitivity in hypomagnesemic DM2 patients.

 

REFERENCES

  1. World Health Organization, Global Report on Diabetes. Geneva, 2016. Accessed 30 August 2016.
  2. Indian Heart Association Why South Asians Facts Web. 30 April 2015.
  3. <http://indianheartassociation.org/why-indians-why-south-asians/overview/>
  4. Kleinfield, N. R. (September 13, 2006). "Modern Ways Open India's Doors to Diabetes". New York Times. Retrieved 8 June 2012.
  5. Bringhurst FR DM, Krane SM, Kronenberg HM. Bone and Mineral Metabolism in Health and Disease. Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine.18th ed. New York: McGraw-Hill; 2012.
  6. F. Guerrero-Romero and M. Rodr´ıguez-Mor´an, “Low serum magnesium levels and metabolic syndrome,” Acta Diabetologica, vol. 39, no. 4, pp. 209–213, 2002.
  7. Ramadass S, Basu S, Srinivasan AR. SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes Metab Syndr. 2015;9:42–45. [PubMed]
  8. Weglicki WB. Hypomagnesemia and inflammation: clinical and basic aspects. Annu Rev Nutr. 2012;32:55–71. [PubMed]
  9. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV,Miller JM, Yanagawa N, Pham PT: Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol 63: 429–436, 2005 [published erratum appears in Clin Nephrol 64: 248, 2005]
  10. Semb S, Helgstrand F, Hjørne F, Bytzer P. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World J Gastroenterol. 2017 Oct 7. 23 (37):6907-6910.
  11. Khubchandani AS, Sanghani H. Study of serum magnesium and HbA1C in diabetic patients along with changes in their lipid profiles.Indian J Clin Prac 2013; 23:717-719.
  12. De Valk HW. Magnesium in diabetes mellitus. Neth J Med. 1999;54(4):139-46.
  13. Senthil manikandan et al..,study on sr,mg and glycemic status in newly detected type 2 diabetic patients. Int J Adv Med.2016 feb;3(1);11-14.
  14. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458:40-47. [PMID: 16808892]
  15. Kauser MM, Afreen A, Prabhakar K, Kumar VSR, Javarappa D. Study of serum magnesium in type 2 Diabetes Mellitus and its correlation with the modality of treatment-A south Indian study. Int J Med Sci Public Health 2014; 5:360-363.
  16. Resnick LM, Altura BT, Gupta RK, Larsh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 diabetes mellitus. Diabetologia. 1993;36:767-70. 16.Garland HO. New experimental data on the relationship between diabetes mellitus and magnesium. Magnes Res. 1992;5(3):193-202.
  17. Sharma A, Dabla S, Agrawal RP, Barjatya H, Kochar DK, Kothari RP. Serum magnesium: an early predictor of course and complications of diabetes mellitus. J IndMed Assoc. 2007;105(1):16- 8,20.
  18. Supriya, Mohanty S, Murgod R, Pinnelli VBK, Raghavendra DS.Hypomagnesemia, Lipid profile and Glycosylated haemoglobin in type 2 Diabetes mellitus patients. International Journal of Chemical and Pharmaceutical Research 2012;1:116-23.
  19. Ankush RD, Suryakar AN, Ankush NR. Hypomagnesaemia in type2 diabetes mellitus patients: a study on the status of oxidative and nitrosative stress. Ind J Clin Biochem 2009;24:184-9.
  20. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147–1152.[PubMed]






Policy for Articles with Open Access:

Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.